IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP

Watchlist Manager
IOL Chemicals and Pharmaceuticals Ltd Logo
IOL Chemicals and Pharmaceuticals Ltd
NSE:IOLCP
Watchlist
Price: 371.65 INR 0.45% Market Closed
Market Cap: 21.8B INR
Have any thoughts about
IOL Chemicals and Pharmaceuticals Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
IOL Chemicals and Pharmaceuticals Ltd

Current Assets 11.2B
Cash & Short-Term Investments 1.5B
Receivables 4.8B
Other Current Assets 4.9B
Non-Current Assets 11.2B
Long-Term Investments 662.8m
PP&E 10.2B
Intangibles 126.1m
Other Non-Current Assets 243.5m
Current Liabilities 5.6B
Accounts Payable 4.7B
Short-Term Debt 327.6m
Other Current Liabilities 580.6m
Non-Current Liabilities 728.9m
Other Non-Current Liabilities 728.9m

Balance Sheet
IOL Chemicals and Pharmaceuticals Ltd

Rotate your device to view
Balance Sheet
Currency: INR
Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023 Mar-2024
Assets
Cash & Cash Equivalents
127
147
164
173
134
281
323
36
14
1 429
Cash
0
137
0
0
134
281
173
36
14
77
Cash Equivalents
127
10
164
173
0
0
150
0
0
1 352
Short-Term Investments
0
6
0
7
163
1 266
3 336
1 381
218
1 351
Total Receivables
574
878
1 335
1 461
2 237
3 033
3 381
5 141
5 525
5 263
Accounts Receivables
327
873
1 128
1 461
1 992
2 781
3 050
4 732
5 062
4 744
Other Receivables
247
5
207
0
245
252
331
408
463
520
Inventory
2 134
2 279
2 626
2 075
2 298
2 096
3 015
4 157
3 346
4 332
Other Current Assets
0
291
0
531
49
33
168
95
101
175
Total Current Assets
2 835
3 601
4 126
4 247
4 881
6 709
10 223
10 808
9 204
11 198
PP&E Net
4 067
4 019
3 951
4 118
4 382
4 879
5 604
6 625
8 326
10 214
PP&E Gross
0
0
0
0
4 382
4 879
5 604
6 625
8 326
10 214
Accumulated Depreciation
0
0
0
0
915
1 258
1 634
2 001
2 416
3 009
Intangible Assets
3
10
9
8
6
4
2
34
89
126
Note Receivable
108
0
90
0
13
12
7
8
28
151
Long-Term Investments
0
0
0
19
69
53
214
2 045
2 504
663
Other Long-Term Assets
3
88
4
130
69
99
58
111
71
92
Total Assets
7 016
N/A
7 717
+10%
8 181
+6%
8 521
+4%
9 419
+11%
11 756
+25%
16 101
+37%
19 623
+22%
20 221
+3%
22 444
+11%
Liabilities
Accounts Payable
702
1 157
1 498
1 576
1 203
1 861
2 388
4 093
3 142
4 692
Accrued Liabilities
0
0
0
0
19
2
0
0
0
0
Short-Term Debt
1 204
1 371
1 408
1 353
677
559
0
428
796
328
Current Portion of Long-Term Debt
0
0
208
285
264
8
9
10
2
0
Other Current Liabilities
178
302
152
233
406
393
508
603
622
581
Total Current Liabilities
2 085
2 830
3 266
3 447
2 569
2 823
2 906
5 134
4 563
5 600
Long-Term Debt
2 771
3 007
2 859
2 581
1 899
27
18
2
0
0
Deferred Income Tax
4
0
0
0
155
726
532
532
564
661
Other Liabilities
84
37
162
336
52
44
41
33
18
68
Total Liabilities
4 944
N/A
5 873
+19%
6 287
+7%
6 364
+1%
4 675
-27%
3 620
-23%
3 497
-3%
5 700
+63%
5 144
-10%
6 329
+23%
Equity
Common Stock
477
562
562
562
569
569
587
587
587
587
Retained Earnings
1 595
1 282
1 332
1 595
2 296
5 702
9 815
11 145
12 302
13 352
Additional Paid In Capital
0
0
0
0
1 903
1 903
2 257
2 257
2 257
2 257
Other Equity
0
0
0
0
24
39
55
67
69
82
Total Equity
2 072
N/A
1 844
-11%
1 894
+3%
2 157
+14%
4 743
+120%
8 135
+72%
12 604
+55%
13 923
+10%
15 077
+8%
16 115
+7%
Total Liabilities & Equity
7 016
N/A
7 717
+10%
8 181
+6%
8 521
+4%
9 419
+11%
11 756
+25%
16 101
+37%
19 623
+22%
20 221
+3%
22 444
+11%
Shares Outstanding
Common Shares Outstanding
48
56
56
56
57
57
57
59
59
59
Preferred Shares Outstanding
0
0
0
0
0
0
0
0
0
0

See Also

Discover More